Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM

By afschroeder • August 29, 2026

Maron MS, Masri A, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Choudhury L, Claggett BL, Coats CJ, de Barros Correia E, Costabel JP, Elliott PM, Silva Enciso JE, Ge J, Ho CY, Kulac I, Lewis GD, Martinez MW, Maurer MS, Michels M, Mitter SS, Pino Moreno JE, Olivotto I, Owens AT, Poulsen SH, Rader F, Rowin EJ, Schulze PC, Sepp R, Sikand N, Solomon SD, Spertus JA, Zhao X, Divanji PH, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Salazar-Mendiguchía J, Wohltman A, Zhuo S, Barriales-Villa R; ACACIA-HCM Investigators. Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM. Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082026. Epub ahead of print. PMID: 42663111.

Tags: aficamten, cardiac myosin, Cardiology/Epi, cardiomyopathy, Cedars Sinai DoM, Clinical Trial, diastolic, heart failure, hypertrophic, Publications, therapy

Association of ramus intermedius with greater overall coronary plaque and stenosis burden

Ansari S, Pourafkari L, Kinninger A, Budoff MJ. Association of ramus intermedius with greater overall coronary plaque and stenosis burden. Int J Cardiovasc Imaging. 2026[...]

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Hegde SM, Wang X, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, de Barros Correia[...]

A Conversation Between Arturo Chiti and Johannes Czernin

Chiti A, Czernin J. A Conversation Between Arturo Chiti and Johannes Czernin. J Nucl Med. 2026 Aug 27:jnumed.126.273671. doi: 10.2967/jnumed.126.273671. Epub ahead of print. PMID:[...]